Additionally, FTO promotes tumor progression in liver, lung, breast, cervical, and colorectal cancers (CRCs) while acting as a tumor suppressor in renal, pancreatic, thyroid, and cholangiocarcinomas.43 Here, FTO is linked to neoplasm.